Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968422 · ClinicalTrials.gov registry record · Phase 1
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT00968422 is a Phase 1 study that has completed, run by Abbott. The registered enrollment target is 28 participants.
The verdict
NCT00968422, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The objectives of this study are to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ABT-384 in elderly subjects.
Interventions
- DRUG ABT-384
- DRUG Matching placebo to ABT-384
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2009-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00968422
The ClinicalTrials.gov registry entry for NCT00968422 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ABT-384 is the first listed.
NCT00968422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00968422 about?
NCT00968422 is a clinical study titled "A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects". The objectives of this study are to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ABT-384 in elderly subjects.
What is the current status of trial NCT00968422?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2009-08.
What interventions are being tested in trial NCT00968422?
The interventions under investigation include: ABT-384 (DRUG), Matching placebo to ABT-384 (DRUG).
Who is sponsoring clinical trial NCT00968422?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.